These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32847701)

  • 1. Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Radtke JP; Nyarangi-Dix J; Wiesenfarth M; Hadaschik B
    Eur Urol; 2021 Jan; 79(1):164-165. PubMed ID: 32847701
    [No Abstract]   [Full Text] [Related]  

  • 2. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
    Aning J; McCoubrie P; Oxley J
    Eur Urol; 2020 Nov; 78(5):e198-e199. PubMed ID: 32839000
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
    Gandaglia G; Montorsi F; Briganti A
    Eur Urol; 2020 Nov; 78(5):e200. PubMed ID: 32800726
    [No Abstract]   [Full Text] [Related]  

  • 5. Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
    Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
    J Urol; 2019 Dec; 202(6):1182-1187. PubMed ID: 31246548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47.
    Morka N; Simpson BS; Emberton M; Norris JM
    Eur Urol Oncol; 2021 Feb; 4(1):127-128. PubMed ID: 33509743
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
    Deniffel D; Salinas E; Ientilucci M; Evans AJ; Fleshner N; Ghai S; Hamilton R; Roberts A; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA; Perlis N
    J Urol; 2020 Dec; 204(6):1187-1194. PubMed ID: 32496160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy.
    Fasciano D; Eich ML; Del Carmen Rodriguez Pena M; Rais-Bahrami S; Gordetsky J
    Int J Surg Pathol; 2020 Feb; 28(1):44-50. PubMed ID: 31342804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.
    Pooli A; Johnson DC; Shirk J; Markovic D; Sadun TY; Sisk AE; Mohammadian Bajgiran A; Afshari Mirak S; Felker ER; Hughes AK; Raman SS; Reiter RE
    J Urol; 2021 Feb; 205(2):444-451. PubMed ID: 33026934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
    Salmasi A; Said J; Shindel AW; Khoshnoodi P; Felker ER; Sisk AE; Grogan T; McCullough D; Bennett J; Bailey H; Lawrence HJ; Elashoff DA; Marks LS; Raman SS; Febbo PG; Reiter RE
    J Urol; 2018 Sep; 200(3):564-572. PubMed ID: 29524506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
    Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
    Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer.
    Tonttila PP; Ahtikoski A; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
    BJU Int; 2019 Dec; 124(6):992-998. PubMed ID: 31102571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography.
    Borghesi M; Bauckneht M; Terrone C
    Eur Urol; 2023 Feb; 83(2):185-186. PubMed ID: 36463074
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
    Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
    Lei Y; Han S; Xing N
    Eur Urol; 2022 May; 81(5):e121. PubMed ID: 35125229
    [No Abstract]   [Full Text] [Related]  

  • 18. Pelvic phased-array mpMRI versus saturation biopsy: a diagnostic performance analysis in men with suspected advanced prostate cancer.
    Liu G; Yan T
    Scand J Urol; 2020 Feb; 54(1):14-19. PubMed ID: 32026731
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
    Samaratunga H; Delahunt B; Egevad L
    Eur Urol; 2022 Jul; 82(1):e15-e16. PubMed ID: 35428506
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
    Marra G; Stabile A; Gontero P; Montorsi F; Briganti A; Gandaglia G;
    Eur Urol; 2022 May; 81(5):e115-e116. PubMed ID: 35151511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.